Cargando…
The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID‐19 Patients: A Retrospective Cohort Study
On March 11, 2020, the World Health Organization declared its assessment of coronavirus disease 2019 (COVID‐19) as a global pandemic. However, specific anti‐severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) drugs are still under development, and patients are managed by multiple complement...
Autores principales: | Shi, Chen, Wang, Cong, Wang, Hanxiang, Yang, Chao, Cai, Fei, Zeng, Fang, Cheng, Fang, Liu, Yihui, Zhou, Taotao, Deng, Bin, Vlodavsky, Israel, Li, Jin‐Ping, Zhang, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719364/ https://www.ncbi.nlm.nih.gov/pubmed/32881340 http://dx.doi.org/10.1111/cts.12880 |
Ejemplares similares
-
Comprehensive Landscape of Heparin Therapy for COVID-19
por: Shi, Chen, et al.
Publicado: (2021) -
Implications of Heparanase on Heparin Synthesis and Metabolism in Mast Cells
por: Maccarana, Marco, et al.
Publicado: (2022) -
The Mechanism behind Influenza Virus Cytokine Storm
por: Gu, Yinuo, et al.
Publicado: (2021) -
Cytokine Storm
por: Fajgenbaum, David C., et al.
Publicado: (2020) -
Quantification of Cytokine Storms During Virus Infections
por: Yuan, Shu, et al.
Publicado: (2021)